Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Published species reactivity||Human|
|Host / Isotype||Mouse|
|Immunogen||Human IGF1R beta|
|Contains||0.1% sodium azide|
|Tested Applications||Dilution *|
|ELISA (ELISA)||Assay Dependent|
|Immunohistochemistry (IHC)||Assay Dependent|
|Western Blot (WB)||2-3 ug/ml|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|Western Blot (WB)||See 2 publications below|
IGF-1R (Insulin-like Growth Factor-1 Receptor) consists of alpha- and beta-subunits, which are disulfide-linked in a beta-alpha-alpha-beta configuration in the mature receptor. The alpha-subunit is completely extracellular, while the beta-subunit spans the membrane and the intracellular portion has intrinsic tyrosine kinase activity.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
The ALK inhibitor ASP3026 eradicates NPM-ALK⁺ T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model.
39-6700 was used in western blot to determine the effects of ASP3026treatment on NPM-ALK+ ALCL cell lines in vitro and on systemic lymphoma growth in vivo
|George SK,Vishwamitra D,Manshouri R,Shi P,Amin HM||Oncotarget (5:5750)||2014|
MicroRNA 96 is a post-transcriptional suppressor of anaplastic lymphoma kinase expression.
39-6700 was used in western blot to study regulation of anaplastic lymphoma kinase expression in cancer cells.
|Vishwamitra D,Li Y,Wilson D,Manshouri R,Curry CV,Shi B,Tang XM,Sheehan AM,Wistuba II,Shi P,Amin HM||The American journal of pathology (180:1772)||2012|
IGFIR, IGFR, CD221, JTK13
IGF-I receptor, insulin-like growth factor 1 receptor, insulin-like growth factor I receptor, soluble IGF1R variant 1, soluble IGF1R variant 2, CD221, IGFIR, IGFR, JTK13